Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this interesting session on Arthritis and children: What is JIA?
Juvenile idiopathic arthritis (JIA) is the most common type of arthritis affecting children and adolescents under the age of 16. It is an autoimmune condition in which the body’s immune system mistakenly attacks its own tissues, leading to inflammation in the joints. This results in symptoms such as joint pain, swelling, stiffness, and reduced mobility. JIA can affect one or multiple joints and, in some cases, may also involve other organs, such as the eyes or skin.
There are several subtypes of JIA, each with different characteristics and levels of severity. While the exact cause is unknown, a combination of genetic and environmental factors is believed to play a role. Early diagnosis and treatment are crucial in managing JIA, as they can prevent long-term joint damage and improve the child’s quality of life. Treatment typically includes medications like NSAIDs, DMARDs, or biologics, along with physical therapy to maintain joint function and mobility.
Therefore, get an overall knowledge of arthritis and children: what is JIA?
See More Webinars @ Hidoc Webinars
1.
A Win for AI in Cancer; 2025's Transformative Drugs; FDA Clarifies 'Underway' Trials
2.
Breast cancer: A new target to eliminate dormant cells before they wake
3.
Is global cancer care losing its human touch?
4.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
5.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
1.
Integrated Updates in Oncology for Specialists
2.
Essential Concepts in Oncology for Better Care
3.
Understanding the HAS-BLED Score: What It Is and Why It Matters
4.
Precision Risk Interception in Oncology: A Comprehensive Review
5.
Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
3.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
4.
Emerging Concepts in Hematology
5.
Immunotherapy: A New Era in Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation